CClinicalTrials.gg
CompletedNCT03942432EvoHSDUpdated Dec 17, 2020

A Prospective, Mono-center, Interventional Study Evaluating the Effect of One Year Initial Care by Hygieno-dietary Advices With or Without Phlebotomy on Glycemia After at Least 5 Years in Patients With Dysmetabolic Iron Overload Syndrome

An interventional study of Oral Glucose Tolerance Test (OGTT) and Clinical exam in Dysmetabolic Iron Overload Syndrome, sponsored by Rennes University Hospital. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-12-17.

Sponsored by Rennes University Hospital · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

A prospective, mono-center, interventional study evaluating the effect of one year initial care by hygieno-dietary advices with or without Phlebotomy on glycemia after at least 5 years in Patients with dysmetabolic iron overload syndrome

Read the detailed description

Dysmetabolic iron overload syndrome (DIOS) is defined by a slight iron overload associated to features of the metabolic syndrome. This is a frequent condition that parallels the increasing prevalence of non alcoholic steato hepatitis. The role of iron overload on insulin sensitivity is described in large cohorts study, with an increased risk of type 2 diabetes in patients with increased serum ferritin, and in vitro where iron load alters key regulators of lipid and glucose metabolism.

In patient with DIOS, improving diet and lifestyle is a major goal, albeit it does not allow to lower body iron stores. Therefore the role of bloodletting in this setting was raised. Several low quality studies suggested a beneficial effect of bloodletting on insulin resistance. Our group demonstrated in a large multicenter randomized trial, the lack of beneficial effect of bloodletting over one year. Because this may be a too short period of time to demonstrate a positive effect we would like to assess the long term effect of iron depletion on insulin resistance and its clinical consequence.

02

Conditions studied

  • Dysmetabolic Iron Overload Syndrome
03

In context

Iron Overload

164 studies on the registry are indexed under Iron Overload; 9 are open to participants now.

This study's enrollment of 75 is above the median of 60 across 106 interventional studies indexed under Iron Overload.

Browse Iron Overload studies →

Lead sponsor

Rennes University Hospital is the lead sponsor of 440 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Persons who participated in the " Phlebotomy " protocol: A Prospective, Randomized Study Comparing Effect of Phlebotomy and Hygieno-dietary Advices With Hygieno-dietary Advices Only on Glycemia in Patients With Dysmetabolic Iron Overload Syndrome
  • Persons affiliated to French Social Security
  • Persons who received an oral and written information on the protocol and signed the informed consent form

Exclusion criteria

Exclusion Criteria:

  • Persons subject to major legal protection (safeguarding justice, guardianship, trusteeship) since their enrolment in the "Phlebotomy" protocol
  • Persons deprived of liberty
  • Pregnant or breastfeeding women
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
75 participants (actual)

Study arms

  • Experimental
    Patients with dysmetabolic iron overload syndrome

    Other: Oral Glucose Tolerance Test (OGTT) · Other: Clinical exam · Biological: Blood sample · Device: MRI · Device: Bioimpedance · Behavioral: Questionnaires

Interventions

  • OtherOral Glucose Tolerance Test (OGTT)

    Blood samples at T0, T30min, T120min

  • OtherClinical exam

    weight, length, waist measurement, cardiac frequency, blood pressure

  • BiologicalBlood sample

    Iron and cardiac markers Serum iron, serum transferrin, transferrin saturation, serum ferritin, AST, ALT, GGT, ALP, PT, Cell Blood Count, ceruloplasminemia , hyaluronic acid, cholesterolemia, HDL, LDL, triglyceridemia, hba1c

  • DeviceMRI

    3 Tesla abdominal MRI

  • DeviceBioimpedance

    Measurement of body composition

  • BehavioralQuestionnaires

    Quality of life, physical activity, alcohol consumption and eating habits

06

What researchers measure

Primary outcomes

  1. Dosage of fasting blood glycemia after 5 years

    Oral Glucose Tolerance Test (OGTT)

    Time frame: Year 5

Secondary outcomes

  1. Dosage of iron hepatic concentration proved by MRI after 5 years

    Abdominal MRI

    Time frame: Year 5

  2. Dosage of iron hepatic concentration after 5 years

    Blood sample

    Time frame: Year 5

  3. Dosage of insulin after 5 years

    Blood sample

    Time frame: Year 5

  4. Measurement of body composition

    Bioimpedance

    Time frame: Year 5

  5. Measurement of insulin resistance markers

    Oral Glucose Tolerance Test (OGTT)

    Time frame: Year 5

  6. Measurement of hepatic steatosis after 5 years

    Abdominal MRI

    Time frame: Year 5

  7. Evaluation of cardiovascular morbi-mortality after 5 years

    Mixed score based on the following events: angina pectoris, cardiac arrest, stoke

    Time frame: Year 5

  8. Calculation of Framingham score

    Appreciation of cardiovascular event after 10 years based on blood pressure, cholesterol level and HDL, smoking or not, age and gender

    Time frame: Year 5

  9. Evaluation of quality of life after 5 years

    SF-36 questionnaire

    Time frame: Year 5

  10. Evaluation of physical activity after 5 years

    Baecke physical activity questionnaire : scores for physical exercise in leisure, leisure and locomotion activities

    Time frame: Year 5

  11. Evaluation of eating habits after 5 years

    Eating habits questionnaire

    Time frame: Year 5

  12. Evaluation of alcohol consumption after 5 years

    Alcohol consumption questionnaire : number of units of alcohol consumed per day

    Time frame: Year 5

07

Study locations

1 site
  • CHU Rennes
    Rennes, 35033, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 17, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03942432
Lead sponsor
Rennes University Hospital
Responsible party
Sponsor
First posted
May 8, 2019
Start date
Jun 11, 2019
Primary completion
Dec 4, 2020
Completion
Dec 4, 2020
Last update
Dec 17, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion